Evidence map›Paper›PMID 42742796›Full record

ArticleIntensive care medicine experimental2026

Correction: Preclinical evidence for supra-clinical acute kidney injury: current biomarkers are not enough.

Justine Serre, David Legouis, Sandrine Placier, Charles Verney, Wionna Desvarieux, David Buob, Juliette Hadchouel, Pierre Galichon

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Intensive care medicine experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Justine SerreInserm, Sorbonne Université, Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine CoRaKiD, Paris, F-75020, France.
David LegouisDivision of Intensive Care Medicine, Department of Anesthesiology, Clinical Pharmacology, Critical Care and Emergency Medicine, Geneva University Hospital, Geneva, Switzerland.
Sandrine PlacierInserm, Sorbonne Université, Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine CoRaKiD, Paris, F-75020, France.
Charles VerneyInserm, Sorbonne Université, Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine CoRaKiD, Paris, F-75020, France.
Wionna DesvarieuxInserm, Sorbonne Université, Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine CoRaKiD, Paris, F-75020, France.
David BuobInserm, Sorbonne Université, Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine CoRaKiD, Paris, F-75020, France.
Juliette Hadchouel *Inserm, Sorbonne Université, Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine CoRaKiD, Paris, F-75020, France. juliette.hadchouel@inserm.fr.ORCID http://orcid.org/0000-0001-8260-6265
Pierre Galichon *Inserm, Sorbonne Université, Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine CoRaKiD, Paris, F-75020, France. pierre.galichon@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42742796
PMCPMC13578171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.